Andrew P. South

6.3k total citations
114 papers, 3.6k citations indexed

About

Andrew P. South is a scholar working on Cell Biology, Molecular Biology and Oncology. According to data from OpenAlex, Andrew P. South has authored 114 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Cell Biology, 46 papers in Molecular Biology and 25 papers in Oncology. Recurrent topics in Andrew P. South's work include Skin and Cellular Biology Research (48 papers), Autoimmune Bullous Skin Diseases (16 papers) and Cell Adhesion Molecules Research (11 papers). Andrew P. South is often cited by papers focused on Skin and Cellular Biology Research (48 papers), Autoimmune Bullous Skin Diseases (16 papers) and Cell Adhesion Molecules Research (11 papers). Andrew P. South collaborates with scholars based in United States, United Kingdom and Mexico. Andrew P. South's co-authors include John A. McGrath, Jon C. Aster, Karin J. Purdie, Irene M. Leigh, Julio C. Salas‐Alanís, Charlotte M. Proby, Raymond J. Cho, Céline Pourreyron, Dean Nižetić and Mei Chen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Andrew P. South

111 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew P. South United States 36 1.5k 1.1k 688 484 477 114 3.6k
Guy Serre France 57 1.8k 1.2× 1.4k 1.2× 859 1.2× 466 1.0× 1.7k 3.6× 200 9.4k
P. Vabres France 29 917 0.6× 483 0.4× 362 0.5× 316 0.7× 620 1.3× 135 2.8k
Kee Yang Chung South Korea 31 899 0.6× 328 0.3× 874 1.3× 665 1.4× 1.3k 2.6× 211 3.5k
Takashi Saku Japan 35 1.4k 0.9× 876 0.8× 1.1k 1.6× 149 0.3× 325 0.7× 201 4.6k
Márcio F. Chedid Brazil 36 2.5k 1.6× 519 0.5× 1.2k 1.8× 388 0.8× 166 0.3× 112 4.8k
Ossama Abbas Lebanon 29 636 0.4× 364 0.3× 427 0.6× 625 1.3× 974 2.0× 165 2.9k
William Damsky United States 32 1.9k 1.2× 389 0.3× 1.6k 2.3× 483 1.0× 838 1.8× 122 4.7k
Joanna Cichy Poland 28 1.1k 0.7× 464 0.4× 610 0.9× 567 1.2× 193 0.4× 72 3.0k
John C. Maize United States 33 751 0.5× 449 0.4× 1.4k 2.0× 1.0k 2.1× 1.2k 2.6× 135 3.8k
Liisa Nissinen Finland 32 1.2k 0.8× 439 0.4× 492 0.7× 420 0.9× 186 0.4× 74 2.8k

Countries citing papers authored by Andrew P. South

Since Specialization
Citations

This map shows the geographic impact of Andrew P. South's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew P. South with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew P. South more than expected).

Fields of papers citing papers by Andrew P. South

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew P. South. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew P. South. The network helps show where Andrew P. South may publish in the future.

Co-authorship network of co-authors of Andrew P. South

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew P. South. A scholar is included among the top collaborators of Andrew P. South based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew P. South. Andrew P. South is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuentes, Ignacia, Neil Patel, John A. Dyer, et al.. (2024). Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa. EMBO Molecular Medicine. 16(4). 870–884.
2.
South, Andrew P., et al.. (2023). Emergence of Malignant T-Cell Intraclonal CDR3 Variants in Mycosis Fungoides. JAMA Dermatology. 159(8). 888–888. 2 indexed citations
3.
LaFleur, Bonnie, et al.. (2023). Characterizing Dermal Transcriptional Change in the Progression from Sun-Protected Skin to Actinic Keratosis. Journal of Investigative Dermatology. 143(7). 1299–1302.e3. 2 indexed citations
4.
Bennett, J., Ya-Lin Huang, Paola Murgas, et al.. (2023). Maintenance of chronicity signatures in fibroblasts isolated from recessive dystrophic epidermolysis bullosa chronic wound dressings under culture conditions. Biological Research. 56(1). 23–23. 3 indexed citations
5.
Gurevich, Irina, Pooja Agarwal, Henry Liu, et al.. (2022). In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial. Nature Medicine. 28(4). 780–788. 99 indexed citations
6.
Youssefian, Leila, Amir Hossein Saeidian, Andrew P. South, et al.. (2021). Knockdown of SDR9C7 Impairs Epidermal Barrier Function. Journal of Investigative Dermatology. 141(7). 1754–1764.e1. 5 indexed citations
7.
Has, Cristina, Andrew P. South, & Jouni Uitto. (2020). Molecular Therapeutics in Development for Epidermolysis Bullosa: Update 2020. Molecular Diagnosis & Therapy. 24(3). 299–309. 45 indexed citations
8.
Li, Pan, Madeleine E. Lemieux, Tom Thomas, et al.. (2020). IER5, a DNA damage response gene, is required for Notch-mediated induction of squamous cell differentiation. eLife. 9. 18 indexed citations
9.
South, Andrew P., Ulrich Rodeck, Ubaldo Martinez‐Outschoorn, et al.. (2020). Cancer-Associated Fibroblast Density, Prognostic Characteristics, and Recurrence in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis. Frontiers in Oncology. 10. 565306–565306. 58 indexed citations
10.
Luginbuhl, Adam, et al.. (2019). Assessment of quality and consistency of monoclonal antibodies for CB1 and CB2 in head and neck squamous cell carcinoma. Head & Neck. 41(9). 3105–3113. 3 indexed citations
11.
Saeidian, Amir Hossein, Leila Youssefian, María G. Moreno‐Treviño, et al.. (2018). Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico. Clinical and Experimental Dermatology. 43(5). 579–584. 7 indexed citations
12.
Zhang, Zhuzhen, Zhenzhen Zi, Eunice E. Lee, et al.. (2018). Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis. Nature Medicine. 24(5). 617–627. 136 indexed citations
13.
South, Andrew P., Karin J. Purdie, Stephen A. Watt, et al.. (2014). NOTCH1 Mutations Occur Early during Cutaneous Squamous Cell Carcinogenesis. Journal of Investigative Dermatology. 134(10). 2630–2638. 245 indexed citations
14.
Guttmann‐Gruber, Christina, Ulrich Koller, Eva M. Murauer, et al.. (2013). The design and optimization of RNA trans‐splicing molecules for skin cancer therapy. Molecular Oncology. 7(6). 1056–1068. 20 indexed citations
15.
Pourreyron, Céline, Julio C. Salas‐Alanís, Jasbani H.S. Dayal, et al.. (2012). Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa. Cancer Research. 72(14). 3522–3534. 103 indexed citations
16.
Pourreyron, Céline, Louise Reilly, Charlotte M. Proby, et al.. (2012). Wnt5a Is Strongly Expressed at the Leading Edge in Non-Melanoma Skin Cancer, Forming Active Gradients, while Canonical Wnt Signalling Is Repressed. PLoS ONE. 7(2). e31827–e31827. 49 indexed citations
17.
Techanukul, Tanasit, J.E. Lai-Cheong, John Mee, et al.. (2012). Mutations in AEC syndrome skin reveal a role for p63 in basement membrane adhesion, skin barrier integrity and hair follicle biology. British Journal of Dermatology. 167(1). 134–144. 23 indexed citations
18.
Martins, Vera, Mei Chen, Karin J. Purdie, et al.. (2009). Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen. Journal of Cell Science. 122(11). 1788–1799. 89 indexed citations
19.
Oyama, Noritaka, Ien Chan, S. M. Neill, et al.. (2004). Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Journal of Clinical Investigation. 113(11). 1550–1559. 35 indexed citations
20.
McLean, W.H. Irwin, Michèle Ramsay, G. C. ASHTON, et al.. (2002). Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene. Journal of Investigative Dermatology. 119(1). 226–226. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guy Serre Breakdown of academic impact, for papers by P. Vabres Breakdown of academic impact, for papers by Kee Yang Chung Breakdown of academic impact, for papers by Takashi Saku Breakdown of academic impact, for papers by Márcio F. Chedid Breakdown of academic impact, for papers by Ossama Abbas Breakdown of academic impact, for papers by William Damsky Breakdown of academic impact, for papers by Joanna Cichy Breakdown of academic impact, for papers by John C. Maize Breakdown of academic impact, for papers by Liisa Nissinen
Rankless by CCL
2026